Burak Alver

Burak Alver has a diverse and extensive work experience. Burak began their career at Massachusetts Institute of Technology (MIT) as a Research Assistant, where they conducted data analysis on large collections of high energy heavy ion collision data sets. Burak led multiple research projects and was the principal author for three major manuscripts. Burak'sdiscovery of "triangular flow" resulted in a paradigm shift in the field of heavy ion physics and their paper on this topic is one of the top 25 most cited nuclear theory papers of all time.

After their time at MIT, Alver joined Harvard Medical School, where they held various roles. Burak served as a Research Fellow in Biomedical Informatics, leading multiple research projects in Epigenetics and Chromatin Structure. Burak analyzed DNA, RNA, and 3C enrichment data and authored over 10 papers. Burak'swork led to the discovery of the role of cancer suppressor SWI/SNF in tissue-specific enhancer regulation. Burak also held several leadership positions, including Scientific Project Manager, Scientific Director of the 4D Nucleome Data Coordination and Integration Center, and Director of the Clinical Genome Analysis Platform.

Alver then joined DaCapo Brainscience as a Consultant in Computational Biology, where they worked until 2023. Burak provided expert guidance in computational biology and data analysis.

Currently, Alver works as the Head of Data Science at the Cystic Fibrosis Foundation.

Burak Alver completed their education with a Bachelor's degree in Physics from Boğaziçi University in 2004. Burak then pursued a Doctor of Philosophy (Ph.D.) in Physics from the Massachusetts Institute of Technology, which they attained in 2010. Prior to that, they attended Robert College for their high school education from 1994 to 2000.